Annexon, Inc.
Anti-complement factor C1q antibodies and uses thereof

Last updated:

Abstract:

The present invention provides anti-C1q antibodies and methods of using the same.

Status:
Grant
Type:

Utility

Filling date:

4 Jan 2019

Issue date:

17 Mar 2020